Feng Hong
Senior Director & Head, Clinical Laboratory Operations, Precision Medicine Regeneron
Seminars
Wednesday 22nd July 2026
Roundtable Discussion: Embedding Liquid Biopsy Infrastructure to De-Risk LBx/CDx Strategy & Enable Scalable Precision Medicine Execution
12:30 pm
- Align assay performance and pre-analytical validation with regulatory-grade CDx requirements to ensure sample integrity, analytical robustness and global approval confidence
- Standardize collection, handling and laboratory workflows across trial networks to reduce variability, protect data quality and enable reproducible, scalable execution
- Integrate translational biomarker strategy with operational laboratory oversight to bridge early molecular insight with decision-grade, clinically deployable implementation
